Mitigating Heterocycle Metabolism in Drug Discovery
- 25 April 2012
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 55 (13), 6002-6020
- https://doi.org/10.1021/jm300343m
Abstract
No abstract availableThis publication has 82 references indexed in Scilit:
- Synopsis of Some Recent Tactical Application of Bioisosteres in Drug DesignJournal of Medicinal Chemistry, 2011
- Discovery and ADMET: Where are we now.Current Topics in Medicinal Chemistry, 2011
- ChEMBL. An interview with John Overington, team leader, chemogenomics at the European Bioinformatics Institute Outstation of the European Molecular Biology Laboratory (EMBL-EBI)Journal of Computer-Aided Molecular Design, 2009
- Role of Biotransformation Studies in Minimizing Metabolism-Related Liabilities in Drug DiscoveryThe AAPS Journal, 2008
- Can the pharmaceutical industry reduce attrition rates?Nature Reviews Drug Discovery, 2004
- Making Better Drugs: Decision Gates in Non-Clinical Drug DevelopmentNature Reviews Drug Discovery, 2003
- Pharmacokinetics and its role in small molecule drug discovery researchMedicinal Research Reviews, 2001
- Role of drug metabolism in drug discovery and developmentMedicinal Research Reviews, 2001
- Optimization of metabolic stability as a goal of modern drug designMedicinal Research Reviews, 2001
- Property-Based Design: Optimization of Drug Absorption and PharmacokineticsJournal of Medicinal Chemistry, 2001